| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/15/2004 | WO2003076589A3 Analysis of apoptotic bodies in bodily fluids |
| 01/15/2004 | WO2003070895A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/15/2004 | WO2003062450A3 Probe correction for gene expression level detection |
| 01/15/2004 | US20040010822 Hydroperoxyde lyases |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010129 Nucleic acid kit for bacterial pathogen diagnosis and method for using the same |
| 01/15/2004 | US20040010081 Immobilized biopolymer |
| 01/15/2004 | US20040009951 DNA deamination mediates innate immunity to (retro)viral infection |
| 01/15/2004 | US20040009938 Methods of enhancing renal uptake of oligonucleotides |
| 01/15/2004 | US20040009936 Vaccine and drug delivery by topical application of vectors and vector extracts |
| 01/15/2004 | US20040009935 Antisense oligonucleotides, targeted to nucleic acids encoding p21-activated kinase 2, that inhibit the expression of the kinase |
| 01/15/2004 | US20040009934 GM-CSF nucleic acid sequences |
| 01/15/2004 | US20040009899 Treating dominant disorders |
| 01/15/2004 | US20040009612 Analyzing nucleotide sequences and detecting restriction fragment length polymorphisms; forensics; heredity testing |
| 01/15/2004 | US20040009602 DNA modifying molecules and methods of use thereof |
| 01/15/2004 | US20040009597 Oligonucleotides for controlling protein tyrosine phosphatase receptor type K gene expression activity and treating diabetes, inflammation and cancer; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040009558 Ligand binding pocket peptide fragment of the estrogen-related receptor 3 (ERR3) and uses thereof |
| 01/15/2004 | US20040009554 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009541 Novel carcinoma-related genes and polypeptides and methods of use thereof |
| 01/15/2004 | US20040009514 Hybridization of a complementary nucleic acid target sequence in a sample to an nucleotide probe, by replacing an attached hybridized probe sequence of a thermo-kinetic reaction, generating a signal by an emitter |
| 01/15/2004 | US20040009513 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 01/15/2004 | US20040009512 Arrays for detection of products of mRNA splicing |
| 01/15/2004 | US20040009504 Cotton event pv-ghgto7(1445) and compositions and methods for detection thereof |
| 01/15/2004 | US20040009498 Chimeric antigen binding molecules and methods for making and using them |
| 01/15/2004 | US20040009496 A composition for optimising bonding of nucleic acid, derived from blood and in an aqueous solution, to a solid phase as well as a kit for isolating nucleic acid |
| 01/15/2004 | US20040009493 Detection of chromosomal abnormalities, such as a chromosomal aneuploidies, deletions, amplifications, and the diagnosis or prognosis of syndromes associated with a contiguous gene abnormality; Kits |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009488 Nucleic acids, proteins, and antibodies |
| 01/15/2004 | US20040009482 Compositions and methods for detecting streptococcus agalactiae surface immunogenic protein genes |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009124 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491497A1 Antisense modulation of insulin-like growth factor 2 expression |
| 01/15/2004 | CA2491137A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1379698A1 Mobility-modified nucleobase polymers and methods of using same |
| 01/14/2004 | EP1379693A2 Bio-barcodes based on oligonucleotide-modified particles |
| 01/14/2004 | EP1379691A1 Differentially methylated sequences in pancreatic cancer |
| 01/14/2004 | EP1379689A2 Oligonucleotide conjugates |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379642A2 Arrayed transfection method and uses related thereto |
| 01/14/2004 | EP1379541A1 Labeled oligonucleotides, methods for making same, and compounds useful therefor |
| 01/14/2004 | EP1379539A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 01/14/2004 | EP1379536A1 Building blocks for the solution phase synthesis of oligonucleotides |
| 01/14/2004 | EP1379264A1 Human secreted proteins |
| 01/14/2004 | EP1379140A2 Production of pancreatic islet cells and delivery of insulin |
| 01/14/2004 | EP1379132A2 Human secreted proteins |
| 01/14/2004 | EP1080231A4 Multimolecular devices, drug delivery systems and single-molecule selection |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468251A Specificity double-chain probe for average-phase detecting nucleic acid and method for implementing the same |
| 01/14/2004 | CN1467291A Avian interleukin-2 (IL-2) gene and eukaryon expressing plasmid and immunity reinforcing agent of bird vaccine |
| 01/14/2004 | CN1467224A Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 01/14/2004 | CN1467218A Application of misplaced dichain oligonucleotide in preparing medicines for treating human liver cancer |
| 01/14/2004 | CN1467217A Structure and uses of autisense oligodeoxynucleotide for treating thrombus disease |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/13/2004 | US6677502 Plant metabolism genes |
| 01/13/2004 | US6677471 Intermediates for the synthesis of oligonucleotide analogues |
| 01/13/2004 | US6677444 Isolated dna encoding melanoma tumor-associated antigen |
| 01/13/2004 | US6677443 Isolated nucleic acid encoding lepidopteran octopamine/ tyramine transporter having sodium-dependent transport activity which has affinity for dopamine and which is inhibited by octopamine and tyramine |
| 01/13/2004 | US6677428 Cdna with nucleotide sequence 1 and protein with amino acid sequence 2 |
| 01/13/2004 | US6677315 Nucleosides for imaging and treatment applications |
| 01/13/2004 | US6677314 Nucleosides for imaging and treatment applications |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677148 Pesticidal proteins |
| 01/13/2004 | US6677122 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/13/2004 | US6677120 Building blocks for the solution phase synthesis of oligonucleotides |
| 01/08/2004 | WO2004003514A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003233A1 Methods to assess quality of microarrays |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003139A2 Modified shine-dalgarno sequences and methods of use thereof |
| 01/08/2004 | WO2004003136A2 Methods of detecting sequence differences |
| 01/08/2004 | WO2004003004A1 Compositions and methods involving inhibiting or enhancing the deubiquitylation of an enzyme |
| 01/08/2004 | WO2004002995A1 Phosphoramidites for coupling oligonucleotides to [2 + 2] photoreactive groups |
| 01/08/2004 | WO2004002508A1 Particles by facile ligand exchange reactions |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002294A2 Plasma or serum marker and process for detection of cancer |
| 01/08/2004 | WO2003078625A3 An improved method for synthesising templated molecules |
| 01/08/2004 | WO2003072051A3 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 01/08/2004 | WO2003064699A3 Apparatus for synthesis of arrays of dna probes |
| 01/08/2004 | WO2003014138A3 Method for immobilizing compounds by means of nitron formation and arrangement for immobilizing compounds |
| 01/08/2004 | WO2003008533A3 Method for virus propagation |
| 01/08/2004 | WO2002044398A3 Universal supports for oligonucleotide synthesis |
| 01/08/2004 | US20040006788 Procedures and materials for conferring disease resistance in plants |
| 01/08/2004 | US20040006786 Novel glycine-rich gene |
| 01/08/2004 | US20040006783 Comprises nucleotide sequences coding a guanosine triphosphatase with a cyclin dependent kinase rac-interactive binding (CRIB) motif for generating transgenic plants with improved growth in decreased oxygen |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction |
| 01/08/2004 | US20040006220 Antisense modulation of insulin-like growth factor 2 expression |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040006203 Method for sequential support-bound synthesis of conjugated oligomeric compounds |
| 01/08/2004 | US20040006039 Neutral sphingomyelinase antisense ribozyme and uses thereof |
| 01/08/2004 | US20040006034 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 01/08/2004 | US20040006032 Vaccination |